ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous System, organized by the American Autonomic Society ...
13d
Gastroesophageal reflux disease linked to increased risk for incident acute myocardial infarction
Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for incident acute myocardial ...
CuraSen Therapeutics has commenced its Phase IIa proof-of-concept trial of CuraAX (CST-3056) with dosing of the first patient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback